Form 8-K - Current report:
SEC Accession No. 0001698530-23-000031
Filing Date
2023-04-27
Accepted
2023-04-27 08:41:00
Documents
14
Period of Report
2023-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20230427.htm   iXBRL 8-K 34919
2 EX-99 a8kexhibit991.htm EX-99 12257
6 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-23-000031.txt   195629

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20230427.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20230427_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20230427_pre.xml EX-101.PRE 13045
8 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20230427_htm.xml XML 11364
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 23852139
SIC: 2834 Pharmaceutical Preparations